I agree with you that it is trial and error for each and everyone but the Associations guidelines don't think that at all and prescribe T4 only.
I have never claimed that T3 is the answer to all. What I have said if members complain is to advise to try some T3 to whatever they are taking.
I am not on here for an argument and everyone is entitled to their own opinion and members post helpful posts of what they found the best route for them.
I have done the rounds of all of the different methods but have now found one that suits me best. I am lucky in that it works for me.
I didn't claim that T3 is the answer to all hypo problems. In fact most people on T4 who aren't doing well DO find an improvement with the addition of some T3.
I think there is some confusion here if you are talking about Graves Patients which I assume (as I know nothing about hyperthyroidism) that their body provides too much T3. That would of course be the cause of their clinical symptoms and their hyperthyroidism?. Just as hypo is a lack of T4.
I am not suggesting overdosing on T3 because if any of us take fraction too much of any thyroid hormones our bodies react in an unpleasant way.
With levo I was in and out of the A&E cardiac Dept like a yo-yo and it was the levo at a lowish dose which caused these severe palps. T3 calmed everything down and I haven't been to see my GP since re clinical symptoms. This is an expert's opinion:-
And ". . . caused strokes"? If anything, the use of T3 may help prevent strokes. I scanned MEDLINE for studies on "T3" and "strokes" published between 1966 and 1997. These key words were mentioned in 43 publications. Most publications reported the beneficial effects of T3 on cardiovascular function. The word "stroke" was most often used in regard to the "stroke work in cardiac contractility" (a physiological description)—not in the sense of cerebrovascular accidents (strokes). I'll mention just a few representative publications. These suggest that it is urgent for the physician you mention—for his patients' welfare—to quickly update his knowledge.
In one study, a researcher found that T3 levels were significantly lower in 42 of 65 stroke patients. [Liang, D.S.: Stroke and thyroid hormones. Chinese Journal of Neurology & Psychiatry, 24(6):352-354, 384, Dec., 1991] It is certainly possible that the low levels of T3 were partly responsible for the strokes. It is well-known that low thyroid hormone levels result in high blood fat levels, and high blood fat levels predispose patients to heart attacks and strokes. By lowering blood fat levels, the use of T3 is likely to help prevent, rather than cause, strokes in some of the above-mentioned physician's patients.
The use of T3 is even beneficial in patients with the most frail heart conditions. Researchers in one study reported, "Triiodothyronine [T3] administration in patients undergoing cardiopulmonary bypass surgery is safe, may lessen the need for pharmacological (vasodilator) therapy, but may increase heart rate." [Vavouranakis, I., et al.: Triiodothyronine administration in coronary artery bypass surgery: effect on hemodynamics. Journal of Cardiovascular Surgery, 35(5):383-389, Oct., 1994]
Many dotors pre 60's doctors did exactly the same, took patients clinical symptoms into consideration and prescribed NDT.
I dont think it is useful to demand that one thyroid hormone is better than another. That's not true. It is only better for the person who gets well.
I also don't think its beneficial to spread rumours or take non-scientific info as truth which frighten people into submission and they may not trial what might be a godsend to them.
Publications. Dr. Lowe has authored more than 160 articles, scientific papers, and book chapters. His writings have appeared many journals, including Psychological Reports; Medical Science Monitor; the Journal of Behavior Therapy and Experimental Psychiatry; the American Journal of Pain Management; Anabolism—A Journal of Preventive Medicine; Medical Hypotheses; Lyon Méditerranée Médical: Médecine du Sud-Est; the British Medical Journal; the Journal of Myofascial Therapy; the Clinical Bulletin of Myofascial Therapy; the Massage Therapy Journal; the Journal of the American Chiropractic Association; and Thyroid Science. Trade papers such as Dynamic Chiropractic, the Chiropractic Journal, and others have published articles and monthly columns by Dr. Lowe.
The authors of at least twenty-three books have cited or described Dr. Lowe's work. Among his own published books are Spasm, Your Guide to Metabolic Health, and The Metabolic Treatment of Fibromyalgia. Study Sphere gave Dr. Lowe its Excellence Award for his chapter in The Metabolic Treatment of Fibromyalgia in which he shows that fibromyalgia is not a psychiatric disorder. In the chapter, he refutes the notion that fibromyalgia is a mental or emotional disorder. He also argues that the misdiagnosis is usually a product of the psychological disturbance of physicians who make the misdiagnosis.
Awards and Memberships. In 1977, the American Chiropractic Association awarded Dr. Lowe its Annual Scientific Paper Award. In 1992, for his contributions to the field of myofascial therapy, the National Association of Myofascial Trigger Point Therapists appointed him an honorary lifetime member. He has served as an official scientific reviewer on the International Reviewers' Panel of Medical Science Monitor, an international journal for experimental and clinical research. As a reviewer, he did critical reviews of submitted research papers in the fields of hypothyroidism and thyroid hormone resistance.
Dr. Lowe is a member of the Board of Medical Advisors of Thyroid UK, and is a member of Index Copernicus Scientists, a global information networking system for scientists. He is Editor-in-Chief of the open-access journal Thyroid Science (www.ThyroidScience.com), which publishes papers on the full range of topics in thyroidology. He formerly served on the Advisory Board of Inside Texas Running Magazine and the Editorial Review Board of the Journal of Bodywork and Movement Therapies. He is a former editor of the Journal of Myofascial Therapy and the Clinical Bulletin of Myofascial Therapy.
In December 2005, Dr. Lowe became a member of Index Copernicus Scientists upon invitation from its CEO Mark R. Graczynski, MD, PhD. Index Copernicus Scientists is a global information networking system for scientists, designed by and for scientists.